Article Details
Retrieved on: 2021-07-01 14:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... with combination design of the novel RNAi drug candidate and immune checkpoint inhibitors, such as PD-1/PD-L1 monoclonal antibodies.
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here